Back to 
BARCLAYS PLC
BARCLAYS PLC
ACXP2 quarters
Position history for BARCLAYS PLC's holdings in ACURX PHARMACEUTICALS INC
Yes. Barclays holds 281 shares of ACXP (Acurx Pharmaceuticals), worth $436, as of its Q2 2026 13F filing. It reduced the position by 99 shares (-26.1%) from Q1 2026. Barclays has held ACXP since Q1 2026, across 2 quarterly 13F filings.
Current Value
$436
Current Shares
281
Total Value Change
-$974
Total Shares Change
-99
Quarter-by-Quarter History
Other major holders of ACXP: JANE STREET GROUP, LLC, VANGUARD CAPITAL MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP